TRIP13 and cancer: A biomarker study involving 165 BC patient samples analyzed the expression levels of four genes (CCNB1, KIF4A, TPX2, and TRIP13) and their association with clinical characteristics, revealing a correlation between elevated CCNB1 expression and cancer stage [60].